ReviewHuman vaccines & immunotherapeutics2015
Adult vaccination: Now is the time to realize an unfulfilled potential.
Review in Human vaccines & immunotherapeutics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 84 citations in OpenAlex.
- Drivers of and barriers to routine adult vaccination: A systematic literature review.Human vaccines & immunotherapeutics · 2022Pooled it
- Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid).Human vaccines & immunotherapeutics · 2016Guideline
- Building on Vaccine Confidence in the Aftermath of the Pandemic: A Qualitative Study in Primary Care Physicians.Vaccines · 2026Article
- Barriers and facilitators for pharmacist-led vaccination services: A systematic review using the Consolidated Framework for Implementation Research (CFIR).Exploratory research in clinical and social pharmacy · 2026Review
- From Trust to Choice: A Cross-Sectional Survey of How Patient Trust in Pharmacists Shapes Willingness and Vaccination Decision Control Preferences.International journal of environmental research and public health · 2025Article
- Stakeholder readiness in the evolving adult vaccine market.iScience · 2025Article
- Interventions to Improve Vaccination Uptake Among Adults: A Systematic Review and Meta-Analysis.Vaccines · 2025Review
- Nonstructural barriers to adult vaccination.Human vaccines & immunotherapeutics · 2024Article
- Adult vaccination coverage in the United States: A database analysis and literature review of improvement strategies.Human vaccines & immunotherapeutics · 2024Review
- Role of new vaccinators/pharmacists in life-course vaccination.Annals of medicine · 2024Review
- Review
- Article
- Review
- Article
- Primary care physicians' perspectives on adults with diabetes and the recommended hepatitis B vaccine: A qualitative study.PloS one · 2024Article
- The Role of Adult Vaccines as Part of Antimicrobial Stewardship: A Scoping Review.Antibiotics (Basel, Switzerland) · 2023Article
- Adult immunization practices, challenges and opportunities in Central America and the Caribbean: Advisory board proceedings.Human vaccines & immunotherapeutics · 2022Article
- Integrating the CARD (Comfort Ask Relax Distract) system in a mass vaccination clinic to improve the experience of individuals during COVID-19 vaccination: a pre-post implementation study.Human vaccines & immunotherapeutics · 2022Article
- Factors and reasons associated with low COVID-19 vaccine uptake among highly hesitant communities in the US.American journal of infection control · 2022Article
- Trends in Adult and Elderly Vaccination: Focus on Vaccination Practices in Tunisia and Morocco.Frontiers in public health · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Each year, vaccine-preventable diseases kill thousands of adults, both in the United States and across the planet, causing a significant human toll and severe economic burden on the world's healthcare systems. In the United States, while immunization is recognized as one of the most effective primary prevention services that improves health and well-being, adult immunization rates remain low and large gaps exist between national adult immunization goals and actual adult immunization rates. Closing these gaps requires a commitment by national leaders to a multifaceted national strategy to: (1) establish the value of adult vaccines in the eyes of the public, payers, policy makers, and health care professionals; (2) improve access to recommended adult vaccinations by improving the adult vaccine infrastructure in the United States and developing public-private partnerships to facilitate effective immunization behaviors; and (3) ensure fair and appropriate payment for adult immunization. Many of the situations that result in low adult immunizations rates in the United States also exist in many other countries around the world. Successful strategies to improve adult immunization coverage rates will result in reductions in morbidity, mortality, and healthcare costs. All medical and public health stakeholders must now collaborate to realize the significant health benefits that come with a strong adult immunization program.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.